AI chatbot to help prostate cancer patients decode their own diagnosis
NCT ID NCT07040501
First seen May 21, 2026 · Last updated May 24, 2026 · Updated 1 time
Summary
This study tests whether ChatGPT, an AI chatbot, can help men with localized prostate cancer better understand their pathology results. Fifty participants who recently had a prostate biopsy will use the chatbot to explain their diagnosis and then meet with their doctor. The goal is to see if AI can improve patient understanding and reduce anxiety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Case Comprehensive Cancer Center, Cleveland Clinic Glickman Urologic Institute
Cleveland, Ohio, 44195, United States
Contact
Conditions
Explore the condition pages connected to this study.